RESPIRA THERAPEUTICS & DESIGN

Class [005]
Inhaled pharmaceuticals administrated by aerosols delivered to patients via oral inhalation comprising therapeutics or diagnostic agents for the treatment or prophylaxis of local lung and systemic diseases of the cardiopulmonary, cardiovascular, endocrine, neuromuscular, orthopedic, and central and peripheral nervous systems, namely, diabetes, hypo-thyroidism, hyper-thyroidism, asthma, chronic obstructive pulmonary disease, emphysema, interstitial lung disease, interstitial pulmonary fibrosis, pulmonary hypertension, cystic fibrosis, fungal infection, viral and bacterial respiratory infections, vaccination for viral and bacterial infections, anaphylactic shock, dyspnea, congestive heart failure, atrial fibrillation, coronary artery disease, hyperlipidemia, anticoagulation, hypertension, Parkinson's disease, Alzheimer's disease, tremor, peripheral pain, central pain, osteoporosis, depression, and sleep disorder